Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Advances in SurgeryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Defining the histopathological changes induced by nonablative radiofrequency treatment of faecal incontinence—a blinded assessment in an animal model.Colorectal Dis. 2015; 17: 433-440
- Augmentation of lower esophageal sphincter pressure and gastric yield pressure after radiofrequency energy delivery to the gastroesophageal junction: a procine model.Gastrointest Endosc. 2000; 52: 81-86
- Radiofrequency energy delivery to the gastric cardia inhibits triggering of transient lower esophageal sphincter relaxation and gastroesophageal reflux in dogs.Gastrointest Endosc. 2003; 57: 17-22
- Changes in gerd symptom scores correlate with improvement in esophageal acid exposure after the Stretta procedure.Surg Endosc. 2004; 18: 1038-1044
- A double -blind sham-controlled study of the effect of radiofrequency energy on symptoms and distensibility of the gastro-esophageal junction in GERD.Am J Gastroenerol. 2012; 107: 222-230
- Improvement of gastroesophageal reflux symptoms after radiofrequency energy: a randomized, sham controlled trial.Gastroenerology. 2003; 125: 668-676
- Clinical trial: radiofrequency energy delivery in proton pump inhibitor dependent gastro-oesopheal reflux disease patients.Aliment Pharmacol Ther. 2008; 28: 1147-1158
- A prospective randomized trial of sham, single-dose stretta, and double-dose Stretta for the treatment of gastroesopheal reflux disease.Surg Endosc. 2010; 24: 818-825
- Treatment of gastroesophageal reflux disease using radiofrequency ablation (stretta procedure): an interim analysis of a randomized trial.Indian J Gastroenterol. 2017; 36: 337-342
- Randomized clinical trial: oesophageal radiofrequencey energy delivery versus sham for PPI-refractory heartburn.Aliment Pharmacol Ther. 2020; 52: 637-645
- Radiofrequency energy delivery to the lower esophageal sphincter reduces esophageal acid exposure and improves GERD symptoms: a systematic review and meta-analysis.Surg Laparosc Endosc Percutan Tech. 2012; 22: 283-288
- No evidence for efficacy of radiofrequency ablation for treatment of gastroesophageal reflux disease: a systematic review and meta-analysis.Clin Gastroenterol Hepatol. 2015; 13: 1058-1067
- Systematic review and meta-analysis of controlled and prospective cohort efficacy studies of endoscopic radiofrequency for treatment of gastroesophageal reflux disease.Surg Endosc. 2017; 31: 4865-4882
- Efficacy of different endoscopic treatments in patients with gastroesophageal reflux disease: a systematic review and network meta-analysis.Surg Endosc. 2012; 35: 1500-1510
- Durability of Stretta Radiofrequency treatment for GERD: results of an 8-year follow-up.Gastroenterol Res Pract. 2014; 2014: 531907
- Long-term maintenance effect of radiofrequency energy delivery for refractory GERD: a decade later.Surg Endosc. 2014; 28: 2323-2333
- Long-term results of radiofrequency energy delivery for the treatmtn of GERD: sustained improvement in symptoms, quality of life and drug use at 4-year follow-up.Gastrointest Endosc. 2007; 65: 361-366
- Fifteen plus years after stretta antireflux endoscopy procedure: quality of life and ppi requirements.Am J Gastroenterol. 2017; 112: ps459-ps460
- Radiofrequency energy delivery to the lower esophageal sphincter improves gastroesophageal reflux patient-reported outcomes in failed laparoscopic Nissen fundoplication cohort.Surg Endosc. 2017; 31: 2854-2862
- The evolution of TIF: transoral incisionless fundoplication.Therap Adv Gastroenterol. 2020; 13 (1756284820924206)
- Transoral incisionless fundoplication: 2-year results from the prospective multicenter U.S. study.Am Surg. 2014; 80: 1093-1105
- Long-term reported outcomes of transoral incisionless fundoplication: an 8-year cohort study.Surg Endosc. 2019; 33: 1304-1309
- Long-term efficacy of transoral incisionless fundoplication with Esophyx (Tif 2.0) and factors affecting outcomes in GERD patients followed for up to 6 years: a prospective single-center study.Surg Endosc. 2015; 29: 2770-2780
- Endoluminal fundoplication (ELF) for GERD using EsophyX: a 12-month follow-up in a single-center experience.J Gastrointest Surg. 2010; 14: 1-6
- Endoscopic, endoluminal fundoplication for gastroesophageal reflux disease: initial experience and lessons learned.Surgery. 2010; 148 ([discussion: 651-643]): 646-651
- Clinical and in vitro analysis of determinants of gastroesophageal competence. A study of the principles of antireflux surgery.Am J Surg. 1979; 137: 39-46
- Analysis of the causes of failed antireflux surgery and the principles of treatment: a review.JAMA Surg. 2015; 150: 585-590
- Transoral incisionless fundoplication offers high patient satisfaction and relief of therapy-resistant typical and atypical symptoms of GERD in community practice.Surg Innov. 2011; 18: 119-129
- Transoral incisionless fundoplication for gastroesophageal reflux disease in an unselected patient population.Surg Endosc. 2010; 24: 854-858
- Transoral incisionless fundoplication for the treatment of gastroesophageal reflux disease.Expert Rev Med Devices. 2014; 11: 341-350
- Surgical treatment of gastroesophageal reflux disease.Surg Clin North Am. 1997; 77: 1063-1082
- Effect of transoral incisionless fundoplication on symptoms, PPI use, and ph-impedance refluxes of GERD patients.World J Surg. 2010; 34: 750-757
- Short-term safety and symptomatic outcomes of transoral incisionless fundoplication with or without hiatal hernia repair in patients with chronic gastroesophageal reflux disease.Am J Surg. 2011; 202 ([discussion: 746-747]): 740-746
- Laparoscopic hiatal hernia repair followed by transoral incisionless fundoplication with EsophyX Device (HH + TIF): Efficacy and Safety in Two Community Hospitals.Surg Innov. 2019; 26: 675-686
- The TEMPO Trial at 5 Years: Transoral Fundoplication (TIF 2.0) Is Safe, Durable, and Cost-effective.Surg Innov. 2018; 25: 149-157
- Transoral Fundoplication offers durable symptom control for chronic GERD: 3-year report from the TEMPO randomized trial with crossover arm.Surg Endosc. 2017; 31: 2498-2508
- PG Mavrelis Efficacy of transoral fundoplication for treatment of chronic gastroesophageal reflux disease incompletely controlled with high-dose proton-pump inhibitors therapy: a randomized, multicenter, open-label, crossover study.BMC Gastroenterol. 2014; 14: 174
- Transoral incisionless fundoplication effective in eliminating GERD symptoms in partial responders to proton pump inhibitor therapy at 6 months: the TEMPO randomized clinical trial.Surg Innov. 2015; 22: 26-40
- A prospective multicenter registry of patients with chronic gastroesophageal reflux disease receiving transoral incisionless fundoplication.J Am Coll Surg. 2012; 215: 794-809
- Univariate and multivariate analyses of preoperative factors influencing symptomatic outcomes of transoral fundoplication.Surg Endosc. 2014; 28: 2949-2958
- The Effects of Transoral Incisionless Fundoplication on Chronic GERD Patients: 12-Month Prospective Multicenter Experience.Surg Laparosc Endosc Percutan Tech. 2014; 24: 36-46
- Efficacy of transoral fundoplication vs omeprazole for treatment of regurgitation in a randomized controlled trial.Gastroenterology. 2015; 148: 324-333.e5
- Randomised clinical trial: transoral incisionless fundoplication vs. sham intervention to control chronic GERD.Aliment Pharmacol Ther. 2015; 42: 1261-1270
- Efficacy of transoral incisionless fundoplication (TIF) for the treatment of GERD: a systematic review with meta-analysis.Surg Endosc. 2017; 31: 1032-1044
- Laparoscopic Nissen fundoplication after failed EsophyX fundoplication.Br J Surg. 2010; 97: 1051-1055
- Laparoscopic anti-reflux revision surgery after transoral incisionless fundoplication is safe and effective.Surg Endosc. 2015; 29: 1746-1752
- The spectrum of surgical remediation of transoral incisionless fundoplication-related failures.J Laparoendosc Adv Surg Tech A. 2018; 28: 1089-1093
- Transoral incisionless fundoplication.Gastrointest Endosc Clin N Am. 2020; 30: 267-289
- Adverse events associated with transoral incisionless fundoplication (TIF) for chronic gastroesophageal reflux disease: a MAUDE database analysis.Surg Endosc. 2021;
- How to choose among fundoplication, magnetic sphincter augmentation or transoral incisionless fundoplication.Curr Opin Gastroenterol. 2019; 35: 371-378
- The changing epidemiology of gastroesophageal reflux disease: are patients getting younger?.J Neurogastroenterology Motil. 2018; 24: 559-569
- ACG clinical guideline for the diagnosis and management of gastroesophageal reflux disease.Am J Gastroenterol. 2022; 117: 27-56
- Endoscopic treatment of proton pump inhibitor-refractory gastroesophageal reflux disease with anti-reflux mucosectomy: Experience of 109 cases.Dig Endosc. 2021; 33: 347-354
- Endoscopic anti-reflux therapy for gastroesophageal reflux disease.World J Gastroenterol. 2021; 27: 6601-6615
- Antireflux mucosectomy band in treatment of refractory gastroesophageal reflux disease: a pilot study for safety, feasibility and symptom control.Endosc Int Open. 2020; 8: E147-E154
- First experience with banded anti-reflux mucosectomy (arms) for gerd: feasibility, safety, and technique.J Gastrointest Surg. 2019; 23: 1274-1278
- Anti-reflux mucosectomy using a cap-assisted endoscopic mucosal resection method for refractory gastroesophageal disease: a prospective feasibility study.Surg Endosc. 2020; 34: 1124-1131
- Comparison of 180° anti-reflux mucosectomy versus 270° anti-reflux mucosectomy for treatment of refractory gastroesophageal reflux disease: a retrospective study.Surg Endosc. 2021; https://doi.org/10.1007/s00464-021-08857-5
- Antireflux Mucosectomy Band (ARM-b) in treatment of refractory gastroesophageal reflux disease after bariatric surgery.Obes Surg. 2020; 30: 4654-4658
- Anti-reflux mucosal ablation (ARMS) as a new treatment for gastroesophageal reflux refractory to proton pump inhibitors: a pilot study.Endosc Int Open. 2020; 8: 133-138
- Anti-reflux mucosectomy (ARMS) results in improved recovery and similar reflux quality of life outcomes compared to laparoscopic Nissen fundoplication.Surg Endosc. 2020; https://doi.org/10.1007/s00464-020-08144-9
Article info
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
